INJECTABLE
  • Animeal

INJECTABLE

SPASMOTOX PLUS INJ

SPASMOTOX PLUS INJ

By UNIQUE

₹ 76
₹ 76
Unlock Unbeatable offers! WhatsApp us now
Tax included. Shipping calculated at checkout.

Out of Stock

Pack - 30mL
Expires on or after: Feb, 2027

Prescription Required question

Title

Check Availability

Rapid 3-4 Day Delivery,Tiny Extra Fee!

  • AnimealPet Safe
  • AnimealBest Quality
  • AnimealFast Delivery
  • AnimealSecure Payment
View full details

Piroxicam, Pitofenone HCl and Fenpiverinium Bromide Veterinary Injection by GMT Pharma International is a cutting-edge, triple-action parenteral formulation developed to provide rapid, multi-dimensional relief from acute pain, inflammation, and visceral smooth muscle spasms in companion animals and livestock. This injectable combination targets the precise physiological cascade responsible for colic, musculoskeletal pain, and spasm-driven visceral discomfort, delivering simultaneous anti-inflammatory, analgesic, spasmolytic, and anticholinergic action through three synergistically active molecules. Suitable for administration across a broad range of species including cattle, horses, dogs, cats, sheep, goats, pigs, and poultry, this prescription-only formulation is designed exclusively for veterinary clinical use. Animeal is proud to offer this rigorously formulated veterinary injectable as part of our professional pharmaceutical catalogue for the practicing veterinarian.

Ingredients:

Piroxicam: Piroxicam is a potent, long-acting oxicam-class non-steroidal anti-inflammatory drug (NSAID) that functions as a non-selective cyclooxygenase (COX-1 and COX-2) inhibitor. By blocking the COX enzyme pathway, piroxicam prevents the conversion of arachidonic acid into prostaglandins and thromboxanes, the key mediators of the pain, fever, and inflammatory response at the tissue level. Its dual inhibition of both COX isoforms provides broad-spectrum anti-inflammatory and analgesic coverage, making it highly effective for acute inflammatory conditions including arthritis, myositis, synovitis, and post-traumatic pain. Its extended half-life relative to other NSAIDs contributes to sustained therapeutic plasma concentrations following a single parenteral dose.

Pitofenone Hydrochloride: Pitofenone HCl is a potent papaverine-like spasmolytic agent that acts by exerting a direct myotropic relaxant effect on unstriated (smooth) muscle tissue. At the cellular level, it inhibits phosphodiesterase activity, which leads to an accumulation of cyclic AMP within smooth muscle cells, resulting in reduced intracellular calcium availability and subsequent smooth muscle relaxation. Additionally, pitofenone inhibits acetylcholinesterase enzyme activity, potentiating the overall antispasmodic effect across the vascular and extravascular smooth muscle of the gastrointestinal tract, urogenital system, and biliary tree. This targeted smooth muscle relaxation alleviates the intense visceral cramping associated with colic and intestinal spasm.

Fenpiverinium Bromide: Fenpiverinium bromide is a quaternary ammonium anticholinergic and antispasmodic compound that acts as a selective muscarinic acetylcholine receptor antagonist at parasympathetic effector sites within smooth muscle. By competitively blocking the binding of acetylcholine to M3 muscarinic receptors on the smooth muscle membrane, fenpiverinium prevents acetylcholine-induced phasic rhythmic contractions and tonic tension development in the gastrointestinal and urogenital smooth muscle. This exclusively anticholinergic mechanism of action is distinct from and complementary to pitofenone's myotropic spasmolysis, creating a dual-pathway antispasmodic effect that is significantly more potent than either agent used alone. The combination of all three molecules produces powerful synergistic analgesic, anti-inflammatory, spasmolytic, and cholinolytic effects predominantly targeting smooth muscle of the gastrointestinal and urogenital tract.

Rapid Multi-Axis Pain Relief via Triple-Molecule Synergy:
The simultaneous activity of an NSAID (piroxicam), a myotropic spasmolytic (pitofenone HCl), and a muscarinic antagonist (fenpiverinium bromide) creates a pharmacological triple-action effect that targets pain, inflammation, and spasm through three independent and synergistic pathways at once. This multi-axis approach delivers faster, more complete relief from acute visceral and musculoskeletal pain than single-agent or dual-agent formulations, making it the preferred choice of veterinarians in complex clinical presentations where spasm and inflammation co-exist.

Targeted Relief from Visceral Colic and Smooth Muscle Spasm:
This formulation is specifically engineered to alleviate the severe smooth muscle contractions responsible for gastrointestinal colic, renal and biliary colic, and urogenital spasm in veterinary patients. Pitofenone and fenpiverinium bromide work at the cellular and receptor level to fully suppress both neurogenic and myogenic spasm, restoring normal intestinal and urogenital motility rapidly and effectively even in acute and severe presentations.

Broad-Spectrum Anti-Inflammatory and Antipyretic Coverage:
Piroxicam's potent COX-1 and COX-2 inhibition addresses the systemic inflammatory response accompanying infectious, traumatic, and surgical conditions, reducing prostaglandin-mediated pain and fever across species. This makes the formulation equally valuable as an anti-inflammatory and antipyretic adjunct in conditions such as pneumonia, mastitis, metritis, lameness, myositis, and post-operative recovery.

Wide Species Applicability Across Veterinary Practice:
Formulated for use across a broad range of animal species including large animals (cattle, horses, buffaloes), small ruminants (sheep, goats), and companion animals (dogs, cats), as well as pigs and poultry, this injectable provides the practicing veterinarian with a single versatile product suitable for mixed and multi-species clinical settings.

Parenteral Delivery for Fast Bioavailability:
As an injectable formulation administered intramuscularly or as directed by a veterinarian, this product bypasses the gastrointestinal barrier entirely, delivering all three active molecules directly into systemic circulation for rapid onset of therapeutic action. This is particularly critical in acute presentations such as colic or severe post-operative pain where immediate relief is clinically essential.

How to Use:

This product is a prescription-only veterinary injectable and must be administered exclusively by a licensed veterinarian or under direct veterinary supervision. The attending veterinarian will determine the appropriate route of administration, which is typically intramuscular (IM), and will calculate the dose based on the species, body weight, severity of the condition, and the individual patient's clinical status. Self-administration by pet owners or farm personnel without veterinary direction is strictly contraindicated.

Storage Advice:

Store unopened Piroxicam, Pitofenone HCl and Fenpiverinium Bromide Veterinary Injection in a cool, dry place below 25 degrees C away from direct sunlight. Do not freeze. Once opened, use the contents promptly and discard any remaining solution in accordance with safe pharmaceutical disposal guidelines, as multi-dose vials should be used under strict aseptic conditions and within the timeframe specified by the manufacturer. Keep the vial tightly sealed when not in use and store it out of reach of children and non-target animals. Do not use after the best-before date printed on the vial label or outer carton.

About the Brand:

GMT Pharma International, established as a partnership firm in 2005 and situated in Kala Amb, Himachal Pradesh, is a leading manufacturer and third-party contract producer of pharmaceutical and veterinary injectable formulations operating under the legacy of Iskon Remedies, with a growing portfolio serving both human health and animal healthcare sectors across India. The company maintains well-functional, GMP-compliant manufacturing infrastructure capable of producing a wide range of injectable categories including beta-lactam antibiotics, general range, and hormonal range products for veterinary applications, with a strong emphasis on quality, safety, and clinical efficacy at every stage of production. GMT Pharma International's commitment to rigorous pharmaceutical standards, veterinary-science-backed formulations, and expanding access to professional-grade animal healthcare solutions aligns with Animeal's commitment to providing veterinarians and pet parents with only the most trusted and effective clinical products. Discover GMT Pharma International today.

Disclaimer:

Please note that while Piroxicam, Pitofenone HCl and Fenpiverinium Bromide Veterinary Injection is formulated from a clinically validated combination of a non-steroidal anti-inflammatory agent, a myotropic spasmolytic, and an anticholinergic antispasmodic, and is appropriate for use in a wide range of animal species including cattle, horses, dogs, cats, sheep, and goats, it is a prescription-only veterinary injectable and must not be purchased, administered, or used without a valid prescription and the direct oversight of a licensed veterinarian. This product is a clinical pharmaceutical intervention and not a complementary supplement; it is not a substitute for a complete veterinary diagnosis, clinical examination, or ongoing treatment plan for chronic conditions. For animals with pre-existing renal impairment, gastrointestinal ulceration or bleeding, cardiac disease, hepatic dysfunction, known hypersensitivity to NSAIDs, or those that are pregnant, lactating, dehydrated, or concurrently receiving diuretics, corticosteroids, or ACE-inhibitor medications, consult your veterinarian before administering this product. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.

Q: Which species and animal categories is this injection suitable for?
This veterinary injection is suitable for use across a broad range of animal species including large animals such as cattle, buffaloes, and horses; small ruminants including sheep and goats; companion animals including dogs and cats; and farm animals including pigs and poultry. It is intended solely for adult animals under veterinary supervision and is not to be used in animals that are dehydrated, known to be hypersensitive to any of its active constituents, or that have a documented history of gastrointestinal ulceration or renal impairment without explicit veterinary clearance.
Q: How frequently should this injection be administered, and who can administer it?
The frequency of administration is determined exclusively by the treating veterinarian based on the animal's species, body weight, clinical condition, and response to treatment. This is a prescription-only injectable and must be administered by or under the direct supervision of a licensed veterinarian; it is not appropriate for unsupervised use by animal owners or farm staff. The veterinarian will prescribe the appropriate dose, route, and duration of the treatment course based on the clinical presentation.
Q: How effective is this injection for treating colic and acute visceral pain in animals?
This formulation is widely recognised in veterinary practice as a highly effective option for the rapid management of acute colic and visceral pain in both large and small animals, owing to its triple-action pharmacological profile. The dual antispasmodic activity of pitofenone HCl and fenpiverinium bromide targets the smooth muscle directly at both the myocyte and receptor levels, while piroxicam addresses the underlying prostaglandin-mediated inflammatory pain cascade, providing broad and rapid symptomatic relief. In acute colic presentations, the parenteral route of delivery ensures a fast onset of action that oral formulations cannot match.
Q: What are the potential side effects and safety considerations of this injection?
As with all NSAID-containing injectable formulations, the most relevant safety considerations include the potential for gastrointestinal irritation or ulceration, particularly with prolonged use or in animals with pre-existing GI sensitivity. Piroxicam's dual COX inhibition can transiently reduce renal perfusion and should be used with caution in dehydrated or renally compromised animals. The anticholinergic component (fenpiverinium bromide) may cause transient tachycardia or reduced salivation in some animals at higher doses. Concurrent use with other NSAIDs, corticosteroids, diuretics, or ACE inhibitors should be avoided unless specifically directed by a veterinarian. Any signs of adverse reaction should be reported to the attending veterinarian immediately.
Q: What makes this triple-combination injectable superior to single-agent NSAID or antispasmodic injections commonly used in veterinary practice?
What differentiates this formulation from conventional single-agent NSAID injections is its simultaneous engagement of three distinct pharmacological targets, targeting the prostaglandin pathway (via piroxicam), the smooth muscle phosphodiesterase pathway (via pitofenone HCl), and the muscarinic receptor pathway (via fenpiverinium bromide) in a single parenteral dose. Research has demonstrated that NSAID molecules such as piroxicam potentiate the antispasmodic activity of pitofenone and fenpiverinium significantly, resulting in a synergistic effect that is measurably superior to the sum of each component used individually. This multi-target approach means faster onset of relief, more complete spasm resolution, and broader coverage of the inflammatory pain cascade, making it a more clinically efficient solution than rotating between separate analgesic and antispasmodic injectable products.
SPASMOTOX PLUS INJ - Animeal
INJECTABLE
🚚 Free above ₹499 in Mumbai · ₹1499 outside
10 DaysEasy Returns
100%Authentic
SecurePayments
INJECTABLE

SPASMOTOX PLUS INJ

By UNIQUE
₹ 68.40
You save ₹ 7.60 (10%)
MRP ₹ 76.00 (Incl. taxes)

Out of Stock

Size

Prescription Required question

₹ 68.40
MRP ₹ 76.00  10% OFF
1
Check Availability

Piroxicam, Pitofenone HCl and Fenpiverinium Bromide Veterinary Injection by GMT Pharma International is a cutting-edge, triple-action parenteral formulation developed to provide rapid, multi-dimensional relief from acute pain, inflammation, and visceral smooth muscle spasms in companion animals and livestock. This injectable combination targets the precise physiological cascade responsible for colic, musculoskeletal pain, and spasm-driven visceral discomfort, delivering simultaneous anti-inflammatory, analgesic, spasmolytic, and anticholinergic action through three synergistically active molecules. Suitable for administration across a broad range of species including cattle, horses, dogs, cats, sheep, goats, pigs, and poultry, this prescription-only formulation is designed exclusively for veterinary clinical use. Animeal is proud to offer this rigorously formulated veterinary injectable as part of our professional pharmaceutical catalogue for the practicing veterinarian.

Ingredients:

Piroxicam: Piroxicam is a potent, long-acting oxicam-class non-steroidal anti-inflammatory drug (NSAID) that functions as a non-selective cyclooxygenase (COX-1 and COX-2) inhibitor. By blocking the COX enzyme pathway, piroxicam prevents the conversion of arachidonic acid into prostaglandins and thromboxanes, the key mediators of the pain, fever, and inflammatory response at the tissue level. Its dual inhibition of both COX isoforms provides broad-spectrum anti-inflammatory and analgesic coverage, making it highly effective for acute inflammatory conditions including arthritis, myositis, synovitis, and post-traumatic pain. Its extended half-life relative to other NSAIDs contributes to sustained therapeutic plasma concentrations following a single parenteral dose.

Pitofenone Hydrochloride: Pitofenone HCl is a potent papaverine-like spasmolytic agent that acts by exerting a direct myotropic relaxant effect on unstriated (smooth) muscle tissue. At the cellular level, it inhibits phosphodiesterase activity, which leads to an accumulation of cyclic AMP within smooth muscle cells, resulting in reduced intracellular calcium availability and subsequent smooth muscle relaxation. Additionally, pitofenone inhibits acetylcholinesterase enzyme activity, potentiating the overall antispasmodic effect across the vascular and extravascular smooth muscle of the gastrointestinal tract, urogenital system, and biliary tree. This targeted smooth muscle relaxation alleviates the intense visceral cramping associated with colic and intestinal spasm.

Fenpiverinium Bromide: Fenpiverinium bromide is a quaternary ammonium anticholinergic and antispasmodic compound that acts as a selective muscarinic acetylcholine receptor antagonist at parasympathetic effector sites within smooth muscle. By competitively blocking the binding of acetylcholine to M3 muscarinic receptors on the smooth muscle membrane, fenpiverinium prevents acetylcholine-induced phasic rhythmic contractions and tonic tension development in the gastrointestinal and urogenital smooth muscle. This exclusively anticholinergic mechanism of action is distinct from and complementary to pitofenone's myotropic spasmolysis, creating a dual-pathway antispasmodic effect that is significantly more potent than either agent used alone. The combination of all three molecules produces powerful synergistic analgesic, anti-inflammatory, spasmolytic, and cholinolytic effects predominantly targeting smooth muscle of the gastrointestinal and urogenital tract.

Rapid Multi-Axis Pain Relief via Triple-Molecule Synergy:
The simultaneous activity of an NSAID (piroxicam), a myotropic spasmolytic (pitofenone HCl), and a muscarinic antagonist (fenpiverinium bromide) creates a pharmacological triple-action effect that targets pain, inflammation, and spasm through three independent and synergistic pathways at once. This multi-axis approach delivers faster, more complete relief from acute visceral and musculoskeletal pain than single-agent or dual-agent formulations, making it the preferred choice of veterinarians in complex clinical presentations where spasm and inflammation co-exist.

Targeted Relief from Visceral Colic and Smooth Muscle Spasm:
This formulation is specifically engineered to alleviate the severe smooth muscle contractions responsible for gastrointestinal colic, renal and biliary colic, and urogenital spasm in veterinary patients. Pitofenone and fenpiverinium bromide work at the cellular and receptor level to fully suppress both neurogenic and myogenic spasm, restoring normal intestinal and urogenital motility rapidly and effectively even in acute and severe presentations.

Broad-Spectrum Anti-Inflammatory and Antipyretic Coverage:
Piroxicam's potent COX-1 and COX-2 inhibition addresses the systemic inflammatory response accompanying infectious, traumatic, and surgical conditions, reducing prostaglandin-mediated pain and fever across species. This makes the formulation equally valuable as an anti-inflammatory and antipyretic adjunct in conditions such as pneumonia, mastitis, metritis, lameness, myositis, and post-operative recovery.

Wide Species Applicability Across Veterinary Practice:
Formulated for use across a broad range of animal species including large animals (cattle, horses, buffaloes), small ruminants (sheep, goats), and companion animals (dogs, cats), as well as pigs and poultry, this injectable provides the practicing veterinarian with a single versatile product suitable for mixed and multi-species clinical settings.

Parenteral Delivery for Fast Bioavailability:
As an injectable formulation administered intramuscularly or as directed by a veterinarian, this product bypasses the gastrointestinal barrier entirely, delivering all three active molecules directly into systemic circulation for rapid onset of therapeutic action. This is particularly critical in acute presentations such as colic or severe post-operative pain where immediate relief is clinically essential.

How to Use:

This product is a prescription-only veterinary injectable and must be administered exclusively by a licensed veterinarian or under direct veterinary supervision. The attending veterinarian will determine the appropriate route of administration, which is typically intramuscular (IM), and will calculate the dose based on the species, body weight, severity of the condition, and the individual patient's clinical status. Self-administration by pet owners or farm personnel without veterinary direction is strictly contraindicated.

Storage Advice:

Store unopened Piroxicam, Pitofenone HCl and Fenpiverinium Bromide Veterinary Injection in a cool, dry place below 25 degrees C away from direct sunlight. Do not freeze. Once opened, use the contents promptly and discard any remaining solution in accordance with safe pharmaceutical disposal guidelines, as multi-dose vials should be used under strict aseptic conditions and within the timeframe specified by the manufacturer. Keep the vial tightly sealed when not in use and store it out of reach of children and non-target animals. Do not use after the best-before date printed on the vial label or outer carton.

About the Brand:

GMT Pharma International, established as a partnership firm in 2005 and situated in Kala Amb, Himachal Pradesh, is a leading manufacturer and third-party contract producer of pharmaceutical and veterinary injectable formulations operating under the legacy of Iskon Remedies, with a growing portfolio serving both human health and animal healthcare sectors across India. The company maintains well-functional, GMP-compliant manufacturing infrastructure capable of producing a wide range of injectable categories including beta-lactam antibiotics, general range, and hormonal range products for veterinary applications, with a strong emphasis on quality, safety, and clinical efficacy at every stage of production. GMT Pharma International's commitment to rigorous pharmaceutical standards, veterinary-science-backed formulations, and expanding access to professional-grade animal healthcare solutions aligns with Animeal's commitment to providing veterinarians and pet parents with only the most trusted and effective clinical products. Discover GMT Pharma International today.

Disclaimer:

Please note that while Piroxicam, Pitofenone HCl and Fenpiverinium Bromide Veterinary Injection is formulated from a clinically validated combination of a non-steroidal anti-inflammatory agent, a myotropic spasmolytic, and an anticholinergic antispasmodic, and is appropriate for use in a wide range of animal species including cattle, horses, dogs, cats, sheep, and goats, it is a prescription-only veterinary injectable and must not be purchased, administered, or used without a valid prescription and the direct oversight of a licensed veterinarian. This product is a clinical pharmaceutical intervention and not a complementary supplement; it is not a substitute for a complete veterinary diagnosis, clinical examination, or ongoing treatment plan for chronic conditions. For animals with pre-existing renal impairment, gastrointestinal ulceration or bleeding, cardiac disease, hepatic dysfunction, known hypersensitivity to NSAIDs, or those that are pregnant, lactating, dehydrated, or concurrently receiving diuretics, corticosteroids, or ACE-inhibitor medications, consult your veterinarian before administering this product. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.

Q: Which species and animal categories is this injection suitable for?
This veterinary injection is suitable for use across a broad range of animal species including large animals such as cattle, buffaloes, and horses; small ruminants including sheep and goats; companion animals including dogs and cats; and farm animals including pigs and poultry. It is intended solely for adult animals under veterinary supervision and is not to be used in animals that are dehydrated, known to be hypersensitive to any of its active constituents, or that have a documented history of gastrointestinal ulceration or renal impairment without explicit veterinary clearance.
Q: How frequently should this injection be administered, and who can administer it?
The frequency of administration is determined exclusively by the treating veterinarian based on the animal's species, body weight, clinical condition, and response to treatment. This is a prescription-only injectable and must be administered by or under the direct supervision of a licensed veterinarian; it is not appropriate for unsupervised use by animal owners or farm staff. The veterinarian will prescribe the appropriate dose, route, and duration of the treatment course based on the clinical presentation.
Q: How effective is this injection for treating colic and acute visceral pain in animals?
This formulation is widely recognised in veterinary practice as a highly effective option for the rapid management of acute colic and visceral pain in both large and small animals, owing to its triple-action pharmacological profile. The dual antispasmodic activity of pitofenone HCl and fenpiverinium bromide targets the smooth muscle directly at both the myocyte and receptor levels, while piroxicam addresses the underlying prostaglandin-mediated inflammatory pain cascade, providing broad and rapid symptomatic relief. In acute colic presentations, the parenteral route of delivery ensures a fast onset of action that oral formulations cannot match.
Q: What are the potential side effects and safety considerations of this injection?
As with all NSAID-containing injectable formulations, the most relevant safety considerations include the potential for gastrointestinal irritation or ulceration, particularly with prolonged use or in animals with pre-existing GI sensitivity. Piroxicam's dual COX inhibition can transiently reduce renal perfusion and should be used with caution in dehydrated or renally compromised animals. The anticholinergic component (fenpiverinium bromide) may cause transient tachycardia or reduced salivation in some animals at higher doses. Concurrent use with other NSAIDs, corticosteroids, diuretics, or ACE inhibitors should be avoided unless specifically directed by a veterinarian. Any signs of adverse reaction should be reported to the attending veterinarian immediately.
Q: What makes this triple-combination injectable superior to single-agent NSAID or antispasmodic injections commonly used in veterinary practice?
What differentiates this formulation from conventional single-agent NSAID injections is its simultaneous engagement of three distinct pharmacological targets, targeting the prostaglandin pathway (via piroxicam), the smooth muscle phosphodiesterase pathway (via pitofenone HCl), and the muscarinic receptor pathway (via fenpiverinium bromide) in a single parenteral dose. Research has demonstrated that NSAID molecules such as piroxicam potentiate the antispasmodic activity of pitofenone and fenpiverinium significantly, resulting in a synergistic effect that is measurably superior to the sum of each component used individually. This multi-target approach means faster onset of relief, more complete spasm resolution, and broader coverage of the inflammatory pain cascade, making it a more clinically efficient solution than rotating between separate analgesic and antispasmodic injectable products.
SPASMOTOX PLUS INJ
₹ 68.40
₹ 76.00  10% OFF

Frequently Asked Questions

Which species and animal categories is this injection suitable for?

This veterinary injection is suitable for use across a broad range of animal species including large animals such as cattle, buffaloes, and horses; small ruminants including sheep and goats; companion animals including dogs and cats; and farm animals including pigs and poultry. It is intended solely for adult animals under veterinary supervision and is not to be used in animals that are dehydrated, known to be hypersensitive to any of its active constituents, or that have a documented history of gastrointestinal ulceration or renal impairment without explicit veterinary clearance.

How frequently should this injection be administered, and who can administer it?

The frequency of administration is determined exclusively by the treating veterinarian based on the animal's species, body weight, clinical condition, and response to treatment. This is a prescription-only injectable and must be administered by or under the direct supervision of a licensed veterinarian; it is not appropriate for unsupervised use by animal owners or farm staff. The veterinarian will prescribe the appropriate dose, route, and duration of the treatment course based on the clinical presentation.

How effective is this injection for treating colic and acute visceral pain in animals?

This formulation is widely recognised in veterinary practice as a highly effective option for the rapid management of acute colic and visceral pain in both large and small animals, owing to its triple-action pharmacological profile. The dual antispasmodic activity of pitofenone HCl and fenpiverinium bromide targets the smooth muscle directly at both the myocyte and receptor levels, while piroxicam addresses the underlying prostaglandin-mediated inflammatory pain cascade, providing broad and rapid symptomatic relief. In acute colic presentations, the parenteral route of delivery ensures a fast onset of action that oral formulations cannot match.

What are the potential side effects and safety considerations of this injection?

As with all NSAID-containing injectable formulations, the most relevant safety considerations include the potential for gastrointestinal irritation or ulceration, particularly with prolonged use or in animals with pre-existing GI sensitivity. Piroxicam's dual COX inhibition can transiently reduce renal perfusion and should be used with caution in dehydrated or renally compromised animals. The anticholinergic component (fenpiverinium bromide) may cause transient tachycardia or reduced salivation in some animals at higher doses. Concurrent use with other NSAIDs, corticosteroids, diuretics, or ACE inhibitors should be avoided unless specifically directed by a veterinarian. Any signs of adverse reaction should be reported to the attending veterinarian immediately.

What makes this triple-combination injectable superior to single-agent NSAID or antispasmodic injections commonly used in veterinary practice?

What differentiates this formulation from conventional single-agent NSAID injections is its simultaneous engagement of three distinct pharmacological targets, targeting the prostaglandin pathway (via piroxicam), the smooth muscle phosphodiesterase pathway (via pitofenone HCl), and the muscarinic receptor pathway (via fenpiverinium bromide) in a single parenteral dose. Research has demonstrated that NSAID molecules such as piroxicam potentiate the antispasmodic activity of pitofenone and fenpiverinium significantly, resulting in a synergistic effect that is measurably superior to the sum of each component used individually. This multi-target approach means faster onset of relief, more complete spasm resolution, and broader coverage of the inflammatory pain cascade, making it a more clinically efficient solution than rotating between separate analgesic and antispasmodic injectable products.
View All Questions